Spero Therapeutics
Highly Engaged Employees
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
675 Massachusetts Ave Ste 14, Cambridge,...Phone Number
(857) 242-1600Website
www.sperotherapeutics.comRevenue
$43 MillionStock Symbol
SPROIndustry
About Spero Therapeutics
Spero Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative medicines for immune-mediated diseases, starting with SP001, an anti-CD40L antibody aimed at treating IgG4-related disease. The company prioritizes programs that align compelling biology with clear patient needs and differentiation from existing treatments. With a proven track record in clinical development, Spero aims to advance therapies that can significantly enhance patients' lives. Their approach includes evaluating SP001's potential in various immune-mediated conditions beyond its initial target.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SPROShow moreSpero Therapeutics Org Chart
Compare Similar Companies to Spero Therapeutics
Compare insights from companies similar to Spero Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Spero Therapeutics Tech Stack
A closer look at the technologies used by Spero Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Spero Therapeutics
Sign Up For FreeTo access detailed company insights
Spero Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative medicines for immune-mediated diseases, starting with SP001, an anti-CD40L antibody aimed at treating IgG4-related disease. The company prioritizes programs that align compelling biology with clear patient needs and differentiation from existing treatm... Read More